The latest COVID-19 member poll from the Global Business Travel Association (GBTA) finds a majority of respondents are optimistic that the travel industry will begin to rebound in mid- to late 2021 and that the availability of the COVID-19 vaccine is top of mind for many business travel professionals. Dave Hilfman, interim executive director, said that what the organization sees in the latest poll are a number of reasons for the business travel industry to be optimistic about 2021, especially toward the middle of the year. He said that as the vaccine rollout gains momentum and if there is a corresponding drop in positive COVID-19 test results, “this survey suggests something of a return to personal connections and in-person meetings and events in the business space.” Three out of four respondents expect employees to attend in-person meetings in the second or third quarter of 2021, with 89% set to attend an in-person meeting or event with attendees outside their company by the third quarter. Also, three in five (59%) say vaccine availability is a “significant factor” in their company’s decision to resume business travel, while one in four (23%) say it is a “moderate” factor and more than one in 10 (14%) are unsure of the impact the vaccine will have on the resumption of business travel. (Totals do not add up to 100% because of rounding.)